GPT and metabolic dysfunction-associated steatotic liver disease: Quarterly treatment with this plant extracts significantly reduces FPG, HbA1c, ALT, AST, cholesterol, triglycerides, total bilirubin and γ-GT as surrogate marker for NAFLD, which consequently reduces the severity of NAFLD and HRI.